Jill DeSimone sold $3.6M of PRAX
director at Praxis Precision Medicines, Inc.. 11,600 shares at an average of $311.32, traded Jun 24, 2026, filed Jun 26, 2026.
Score components
- +15RoleDirector
- +25Trade size$3.6M at market
- +20Share of holdings soldSold 83% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001930479-26-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | MOption exercise Common Stock10b5-1 | +8,566 | $44.25 | $379k | 10,903 | Jun 26, 2026 |
| Jun 24, 2026 | MOption exercise Common Stock10b5-1 | +3,034 | $147.30 | $447k | 13,937 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -10 | $301.44 | $3,014 | 13,927 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -120 | $303.13 | $36k | 13,807 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -320 | $305.31 | $98k | 13,487 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -683 | $306.77 | $210k | 12,804 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -1,240 | $308.24 | $382k | 11,564 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -999 | $309.38 | $309k | 10,565 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -1,750 | $310.89 | $544k | 8,815 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -2,854 | $311.91 | $890k | 5,961 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -1,004 | $312.83 | $314k | 4,957 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -504 | $313.66 | $158k | 4,453 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -1,279 | $314.90 | $403k | 3,174 | Jun 26, 2026 |
| Jun 24, 2026 | SOpen-market sale Common Stock10b5-1 | -837 | $315.71 | $264k | 2,337 | Jun 26, 2026 |
| Jun 24, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,566 | $0.00 | $0 | 0 | Jun 26, 2026 |
| Jun 24, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,034 | $0.00 | $0 | 0 | Jun 26, 2026 |
Related signals
Other insiders at Praxis Precision Medicines, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | Praxis Precision Medicines, Inc. | Lauren Mastrocola Principal Accounting Officer | $2.6M 13,600 shares | -57% | |
| 53Moderate | Praxis Precision Medicines, Inc. | Alex Nemiroff General Counsel and Secretary | $4.9M 25,130 shares | -55% | |
| 42Moderate | PRAXsell Praxis Precision Medicines, Inc. | Adage Capital Management, L.P. owner | $33M 313,910 shares | -13% | |
| 34Weak | Praxis Precision Medicines, Inc. | Lauren Mastrocola Principal Accounting Officer | $424k 5,188 shares | -48% | |
| 38Weak | Praxis Precision Medicines, Inc. | Alex Nemiroff General Counsel and Secretary | $661k 8,239 shares | -44% | |
| 39Weak | PRAXbuy Praxis Precision Medicines, Inc. | Marcio Souza Chief Executive Officer | $11k 10,000 shares | +29% | |
| 61Notable | Praxis Precision Medicines, Inc. | Timothy Edwin Kelly Chief Financial Officer | $6,998 8,000 shares | +21% | |
| 61Notable | Praxis Precision Medicines, Inc. | Timothy Edwin Kelly Chief Financial Officer | $6,998 8,000 shares | +21% | |
| 64Notable | Praxis Precision Medicines, Inc. | Dean J Mitchell director | $42k 50,000 shares | +200% | |
| 71Notable | Praxis Precision Medicines, Inc. | Marcio Souza Chief Executive Officer | $60k 70,002 shares | +37% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.